Our lawyers at Abbott Law Group are now reviewing claims for people injured by Actemra, a rheumatoid arthritis drug linked to life threatening side affects that may caused hundreds of deaths.
If you or loved one experienced life threatening side effects taking Actemra, please contact our Actemra class action lawyers at Abbott Law Group.
According to a comprehensive STAT report published on June 2017, numerous individuals have perished after using Actemra-a rheumatoid drug used in treating arthritis. The report discovers a subsequent increase in the risk of stroke, heart attack, GI perforation and lung failure. Despite having identified no direct link, the report indicates an alarming trend identifying more than 1128 pulmonary and cardiovascular deaths particularly in patients suffering from Actemra reported to FDA.
Actemra (tocilizumab) is simply an injectable drug which works through minimizing effects of a special substance found in the human body that leads to inflammation. This medication is approved as a treatment for acute rheumatoid arthritis, polyarticular juvenile idiopathic arthritis (PJIA), systemic juvenile idiopathic arthritis (SJIA), and finally giant cell arteritis. For most users, the doses are repeated on a 4-week regular basis although it is subject to change on basis of laboratory assessments.
Despite their effectiveness, Immunosuppressive agents come with numerous risks. As such, FDA requires such medication such as IL-2 inhibitors to have warnings on the high risk of severe infections such as tuberculosis, invasive fungal infection or even opportunistic infections. Generally, they include warnings or safety information about lung disease, heart failure, stroke/heart attack and pancreatitis all which are fatal.
However, Actemra omits these particular risks which may, therefore, mislead users to thinking that it is safer. Unfortunately, latest STAT news releases report that these risks might be greater than formerly listed or identified on these types of drugs. With this new discovery, STAT News releases have reiterated the need for immunosuppressive drug packages such as for Actemra to include warnings about severe risks of stroke, heart attack, GI tears/perforation and lung disease.
Severe side effects of using Actemra may include:
The use of Actemra has also been linked with acute allergic reactions such as anaphylaxis and even death. Some of the allergic reactions symptoms include:
The use of Actemra is closely linked to a higher-than-normal likelihood of GI perforation. The situation gets even worse where the patient is taking drugs that are known to subsequently irritate GI tracts such as NSAIDS, methotrexate or corticosteroids.
Patients and consequent family members of anyone who has been harmed whilst taking Actemra and other similar drugs are eligible for some sort of compensation for their respective injuries. Past medical claims of this nature have culminated into monetary compensation for among others; medical costs, suffering and pain, and lost wages. In some instances, if it is determined that the drug manufacturer knowingly concealed the dangers that come with its use, plaintiffs have benefited through receiving punitive damages.
With this in mind, it is important for patients or relatives of victims who have experienced a stroke, lung disease, and heart failure or have even died as a result of taking Actemra to take legal action.
June 5, 2017, STAT News, Hundreds died while taking an arthritis drug, but nobody alerted patients
June 7, 2017, PharmaLive, Hundreds of Patient Deaths Linked to Roche’s RA Drug Actemra